UNSPSC 51283509: Dicloxacillin sodium

This classification denotes a penicillin antibiotic with the molecular formula C19H16Cl2N3O5S.Na.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 4HZT2V9KX0, chemically known as monosodium (2s,5r,6r)-6-(3-(2,6-dichlorophenyl)-5-methyl-4-isoxazolecarboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate monohydrate, but more generally known as dicloxacillin sodium, which bears US NIH Compound Identifier 6098.

UNSPSC 51283509 Dicloxacillin sodium is a Commodity code that, based on recent state and local solicitation activity, does not align with actual procurement patterns under this designation. The code nominally covers a specific antibiotic pharmaceutical product, yet the recent opportunities tagged to it reflect broad procurement of naloxone, drug deactivation systems, medical and first aid supplies, and multi-source generic pharmaceuticals and over-the-counter products. State and local health departments, fire rescue divisions, cooperative purchasing alliances, and health and human services commissions are soliciting these supplies through competitive bidding processes and RFPs, but dicloxacillin sodium as a discrete product line does not appear in the documented scope. The mismatch suggests either a tagging error in the source data or that this Commodity code is being used as a placeholder for broader pharmaceutical procurement categories.

The recent opportunities show activity across Florida, Texas, Minnesota, and Oregon within cooperative purchasing frameworks and direct municipal procurement. Seminole County, Florida issued IFB 60459723LAS (due July 26, 2023) for naloxone and drug deactivation systems with quarterly deliveries to the county health building; the City of Tampa issued ITB 26P00145 (due March 13, 2026) for medical and first aid supplies to its Fire Department Rescue Division, estimated at $700,000 and set aside for certified Small Local Business Enterprises; the Texas Health and Human Services Commission posted RFI HHS0017013 (April 3, 2026) exploring direct-to-manufacturer prescription programs; and the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) issued RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products distributed through authorized wholesalers. No recent solicitations specifically name dicloxacillin sodium as a line item or procurement focus.